This review summarizes the latest advances in the beneficial therapeutic effects of Lingzhi/Yunzhi in overcoming drug resistance, strengthening immunity, and improving clinical outcomes in EGFR-mutated NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.